Paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of diffuse DES in-stent

来源 :第十二届中国介入心脏病学大会(CIT2014) | 被引量 : 0次 | 上传用户:zhou1225
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background Treatment of drug-eluting stent in-stent restenosis (DES-ISR) is still challenging especially in diffuse lesions.The intention of this subgroup analysis is to compare the safety and effectiveness of paclitaxel-coated balloon (PCB) versus paclitaxel-eluting stent (PES) in the treatment of patients with diffuse DES-ISR.
其他文献
Background ST-segment elevation myocardial infarction (STEMI) patients are often accompanied with multivessel disease.The current guideline recommended treating the culprit vessel at the primary percu
会议
Background This article reports the 2-year clinical outcomes of the abtuminal groove-filled biodegradable polymer sirolimus-eluting stent (SES) FIREHAWK (MicroPort Medical,Shanghai,China) compared wit
会议
Background To investigate the effects of atorvastatin on contrast-induced nephropathy (CIN) in patients with acute coronary syndrome (ACS) undergoingselective coronary angiography (CAG) or percutaneou
会议
Background Recently,several studies indicated that ischemic post-conditioning can reduce infarct size and improve heart function.We made the meta-analysis to investigate whether postconditioning prote
会议
Background To evaluate the effects of trimetazidine on left ventricular function and thehibemafing myocardium by 18FDG PET-CT in patients with ischemic cardiomyopathy.Methods 60 cases with ischemic ca
会议
Background The feasibility,efficacy and safety of transradial (TR) versus transfemoral (TF) methods of percutaneous coronary intervention (PCI) for unprotected left main coronary artery (ULMCA) diseas
会议
Background Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) implantation has been considered an altemative therapy to cardiac surgery for left main (LM) patients with low to mod
会议
Background Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) implantation has been considered an alternative therapy to cardiac surgery for left main (LM) patients with low to mo
会议
Background Clopidogrel and statin are strongly recommended after percutaneous coronary intervention,and administration of high dose statin can notably improve prognosis in elder patients with high ris
会议
Background Treatment of drug-eluting stent in-stent restenosis (DES-ISR) is still challenging especially in small coronary arteries.The intention of this sub-group analysis is to compare the safety an
会议